These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3439980)

  • 1. [Use of the CS-3000 Cell Separator (Fenwal) for therapeutic lymphocyte depletion in thrombocytopenic patients with chronic lymphatic leukemia (CLL)].
    Brauer H; Aulmann HM; Wassmann A; Stangel W; Le Blanc S; Diedrich H; Meinicke K; Poliwoda H
    Beitr Infusionther Klin Ernahr; 1987; 18():230-3. PubMed ID: 3439980
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic cytapheresis using the Fenwal CS-3000 blood cell separator.
    Steeper TA; Smith JA; McCullough J
    Vox Sang; 1985; 48(4):193-200. PubMed ID: 3984305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donors leukapheresis on Fenwal CS-3000.
    Kotelba-Witkowska B; Mrowiec ZR; Daszyński J; Skrzeczkowska E
    Mater Med Pol; 1990; 22(1):33-5. PubMed ID: 2079859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphoma.
    Cooper IA; Ding JC; Adams PB; Quinn MA; Brettell M
    Am J Hematol; 1979; 6(4):387-98. PubMed ID: 316970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic lymphapheresis in leukostasis-induced priapism].
    Strobel E; Howe J; Bäcker U; Ernst G; Mempel M
    Dtsch Med Wochenschr; 1987 Dec; 112(51-52):1984-5. PubMed ID: 3691330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukapheresis: increasing the granulocyte yield with the Fenwal CS-3000.
    Loftus TJ; White RF; Huestis DW
    J Clin Apher; 1983; 1(2):109-14. PubMed ID: 6681481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic leukapheresis in a patient with prolymphocytic transformation of B-cell chronic lymphocytic leukemia.
    Steenssens L; Van Camp B
    Int J Artif Organs; 1984 May; 7(3):139-42. PubMed ID: 6610651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of the cell separator in the treatment of leukemia].
    Höcker P; Pittermann E; Gobets M; Pawlowsky J; Flegel U; Stacher A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):283-94. PubMed ID: 52575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discontinuous cell separation as depletion therapy in chronic leukemias].
    Graubner M; Waldschmidt R; Kretschmer V; Mueller-Eckhardt C; Löffler H
    Onkologie; 1981 Jun; 4(3):162-7. PubMed ID: 7022292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation of therapeutic doses of leukocytes and thrombocytes using a blood cell separator].
    Bláha M; Vanasek J; Malý J; Siroký O; Pecka M
    Gematol Transfuziol; 1983 Oct; 28(10):23-5. PubMed ID: 6654008
    [No Abstract]   [Full Text] [Related]  

  • 11. Continuous-flow leukapheresis for rapid cytoreduction in leukemia.
    Lane TA
    Transfusion; 1980; 20(4):455-7. PubMed ID: 6931450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of long-term leukapheresis in the treatment of adult T-cell leukemia.
    Yamauchi K; Noguchi K; Shimizu M; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1982 Nov; 7(6):655-60. PubMed ID: 6985175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetics of the lymphocytes of patients with chronic lymphatic leukemia following lymphocytopheresis].
    Guseĭnov TN; Kotel'nikov VM; Dul'tsina SM; Kalinin NN; Polianskaia AM
    Probl Gematol Pereliv Krovi; 1982 Jul; 27(7):43-6. PubMed ID: 7122456
    [No Abstract]   [Full Text] [Related]  

  • 14. Depletion lymphocytapheresis in chronic lymphocytic leukemias: criteria for predicting which patients will respond to treatment.
    Rossi PL; Alfano G; D'Onofrio G; Menichella G; Mango G
    Int J Artif Organs; 1986 Jan; 9(1):59-62. PubMed ID: 3957456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibilities and results of the use of a cell separator in hematology].
    Stacher VA; HOCKER P; Pittermann E
    Wien Med Wochenschr; 1975 Jan; 125(1-3):35-44. PubMed ID: 236623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombocytopenia in chronic lymphocytic leukemia. Therapeutic results].
    Evensen SA; Stavem P; Carlsen E; Blichfeldt P; Mølstad P
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1395-6. PubMed ID: 6623446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of platelet and leukocyte content in platelet concentrates obtained from CS-3000 and third generation (CS-3000 plus and Cobe-Spectra) cell separators].
    Dzieciatkowska A; Fuksiewicz M; Lachert E; Ziemba-Zółtowska B; Letowska M
    Acta Haematol Pol; 1995; 26(3):285-9. PubMed ID: 8525774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic progenitor cell large volume leukapheresis (LVL) on the Fenwal Amicus blood separator.
    Burgstaler EA; Pineda AA; Winters JL
    J Clin Apher; 2004; 19(2):103-11. PubMed ID: 15274204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombocyte aggregate formation during thrombocyte concentrate preparation with the CS-3000 Cell Separator (Fenwal) and its effects on the analysis of the concentrate with the Coulter Counter S Plus IV].
    Wassmann A; Aulmann HM; Stangel W; Meinicke K
    Beitr Infusionther Klin Ernahr; 1987; 18():216-8. PubMed ID: 3439976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.